APO Research

APO RESEARCH · REPORT

Non-lethal Biochemical Weapons

Selected research

Industry Growth & Trends

Global Non-lethal Biochemical Weapons Industry Growth and Trends Forecast to 2032

Market perspective

The global Non-lethal Biochemical Weapons market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-lethal Biochemical Weapons include Lamperd Less Lethal, BAE Systems, Inc., QinetiqGroup, Inc., General Dynamics Corporation, TASER International,Inc., Moog, Inc., Raytheon Company, Chemring Group PLC. and Textron Systems, Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-lethal Biochemical Weapons market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-lethal Biochemical Weapons market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-lethal Biochemical Weapons market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-lethal Biochemical Weapons.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-lethal Biochemical Weapons market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-lethal Biochemical Weapons Market by Company

Lamperd Less Lethal

BAE Systems, Inc.

QinetiqGroup, Inc.

General Dynamics Corporation

TASER International,Inc.

Moog, Inc.

Raytheon Company

Chemring Group PLC.

Textron Systems, Corp

LRAD Corporation

Non-lethal Biochemical Weapons Segment by Type

Directed Energy

Direct Contact

Non-lethal Biochemical Weapons Segment by Application

Military Forces

Law Enforcement Agencies

Non-lethal Biochemical Weapons Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-lethal Biochemical Weapons market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-lethal Biochemical Weapons and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-lethal Biochemical Weapons.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-lethal Biochemical Weapons manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-lethal Biochemical Weapons in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Directed Energy Table 2. Major Company of Direct Contact Table 3. Global Non-lethal Biochemical Weapons Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 5. Global Non-lethal Biochemical Weapons Sales Market Share in Volume by Type (2021-2026) Table 6. Global Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (US$ Million) Table 7. Global Non-lethal Biochemical Weapons Sales Market Share in Value by Type (2021-2026) Table 8. Global Non-lethal Biochemical Weapons Price by Type (2021-2026) & (USD/unit) Table 9. Global Non-lethal Biochemical Weapons Sales by Type (2027-2032) & (k units) Table 10. Global Non-lethal Biochemical Weapons Sales Market Share in Volume by Type (2027-2032) Table 11. Global Non-lethal Biochemical Weapons Sales by Type (2027-2032) & (US$ Million) Table 12. Global Non-lethal Biochemical Weapons Sales Market Share in Value by Type (2027-2032) Table 13. Global Non-lethal Biochemical Weapons Price by Type (2027-2032) & (USD/unit) Table 14. North America Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 15. North America Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 17. Europe Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 21. Latin America Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (US$ Million) Table 24. Non-lethal Biochemical Weapons Industry Trends Table 25. Non-lethal Biochemical Weapons Industry Drivers Table 26. Non-lethal Biochemical Weapons Industry Opportunities and Challenges Table 27. Non-lethal Biochemical Weapons Industry Restraints Table 28. Global Non-lethal Biochemical Weapons Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Non-lethal Biochemical Weapons Revenue Market Share by Company (2021-2026) Table 30. Global Non-lethal Biochemical Weapons Sales by Company (2021-2026) & (k units) Table 31. Global Non-lethal Biochemical Weapons Sales Share by Company (2021-2026) Table 32. Global Non-lethal Biochemical Weapons Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Non-lethal Biochemical Weapons Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Non-lethal Biochemical Weapons Major Company Production Sites and Headquarters Table 35. Global Non-lethal Biochemical Weapons Company, Product Type & Application Table 36. Global Non-lethal Biochemical Weapons Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Non-lethal Biochemical Weapons by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Non-lethal Biochemical Weapons Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Non-lethal Biochemical Weapons Sales by Region (2021-2026) & (k units) Table 41. Global Non-lethal Biochemical Weapons Sales Market Share in Volume by Region (2021-2026) Table 42. Global Non-lethal Biochemical Weapons Sales by Region (2021-2026) & (US$ Million) Table 43. Global Non-lethal Biochemical Weapons Sales Market Share in Value by Region (2021-2026) Table 44. Global Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Non-lethal Biochemical Weapons Sales by Region (2027-2032) & (k units) Table 46. Global Non-lethal Biochemical Weapons Sales Market Share in Volume by Region (2027-2032) Table 47. Global Non-lethal Biochemical Weapons Sales by Region (2027-2032) & (US$ Million) Table 48. Global Non-lethal Biochemical Weapons Sales Market Share in Value by Region (2027-2032) Table 49. Global Non-lethal Biochemical Weapons Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Non-lethal Biochemical Weapons Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 52. Global Non-lethal Biochemical Weapons Sales Market Share in Volume by Application (2021-2026) Table 53. Global Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (US$ Million) Table 54. Global Non-lethal Biochemical Weapons Sales Market Share in Value by Application (2021-2026) Table 55. Global Non-lethal Biochemical Weapons Price by Application (2021-2026) & (USD/unit) Table 56. Global Non-lethal Biochemical Weapons Sales by Application (2027-2032) & (k units) Table 57. Global Non-lethal Biochemical Weapons Sales Market Share in Volume by Application (2027-2032) Table 58. Global Non-lethal Biochemical Weapons Sales by Application (2027-2032) & (US$ Million) Table 59. Global Non-lethal Biochemical Weapons Sales Market Share in Value by Application (2027-2032) Table 60. Global Non-lethal Biochemical Weapons Price by Application (2027-2032) & (USD/unit) Table 61. North America Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 62. North America Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 64. Europe Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 68. Latin America Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (US$ Million) Table 71. Lamperd Less Lethal Company Information Table 72. Lamperd Less Lethal Business Overview Table 73. Lamperd Less Lethal Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Lamperd Less Lethal Non-lethal Biochemical Weapons Product Portfolio Table 75. Lamperd Less Lethal Recent Development Table 76. BAE Systems, Inc. Company Information Table 77. BAE Systems, Inc. Business Overview Table 78. BAE Systems, Inc. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. BAE Systems, Inc. Non-lethal Biochemical Weapons Product Portfolio Table 80. BAE Systems, Inc. Recent Development Table 81. QinetiqGroup, Inc. Company Information Table 82. QinetiqGroup, Inc. Business Overview Table 83. QinetiqGroup, Inc. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. QinetiqGroup, Inc. Non-lethal Biochemical Weapons Product Portfolio Table 85. QinetiqGroup, Inc. Recent Development Table 86. General Dynamics Corporation Company Information Table 87. General Dynamics Corporation Business Overview Table 88. General Dynamics Corporation Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. General Dynamics Corporation Non-lethal Biochemical Weapons Product Portfolio Table 90. General Dynamics Corporation Recent Development Table 91. TASER International,Inc. Company Information Table 92. TASER International,Inc. Business Overview Table 93. TASER International,Inc. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. TASER International,Inc. Non-lethal Biochemical Weapons Product Portfolio Table 95. TASER International,Inc. Recent Development Table 96. Moog, Inc. Company Information Table 97. Moog, Inc. Business Overview Table 98. Moog, Inc. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Moog, Inc. Non-lethal Biochemical Weapons Product Portfolio Table 100. Moog, Inc. Recent Development Table 101. Raytheon Company Company Information Table 102. Raytheon Company Business Overview Table 103. Raytheon Company Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Raytheon Company Non-lethal Biochemical Weapons Product Portfolio Table 105. Raytheon Company Recent Development Table 106. Chemring Group PLC. Company Information Table 107. Chemring Group PLC. Business Overview Table 108. Chemring Group PLC. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Chemring Group PLC. Non-lethal Biochemical Weapons Product Portfolio Table 110. Chemring Group PLC. Recent Development Table 111. Textron Systems, Corp Company Information Table 112. Textron Systems, Corp Business Overview Table 113. Textron Systems, Corp Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Textron Systems, Corp Non-lethal Biochemical Weapons Product Portfolio Table 115. Textron Systems, Corp Recent Development Table 116. LRAD Corporation Company Information Table 117. LRAD Corporation Business Overview Table 118. LRAD Corporation Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. LRAD Corporation Non-lethal Biochemical Weapons Product Portfolio Table 120. LRAD Corporation Recent Development Table 121. North America Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 123. North America Non-lethal Biochemical Weapons Sales Market Share by Country (2021-2026) Table 124. North America Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Non-lethal Biochemical Weapons Sales Market Share Forecast by Country (2027-2032) Table 126. North America Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Non-lethal Biochemical Weapons Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Non-lethal Biochemical Weapons Market Share by Country (2021-2026) Table 129. North America Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Non-lethal Biochemical Weapons Market Share Forecast by Country (2027-2032) Table 131. Europe Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 133. Europe Non-lethal Biochemical Weapons Sales Market Share by Country (2021-2026) Table 134. Europe Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Non-lethal Biochemical Weapons Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Non-lethal Biochemical Weapons Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Non-lethal Biochemical Weapons Market Share by Country (2021-2026) Table 139. Europe Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Non-lethal Biochemical Weapons Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Non-lethal Biochemical Weapons Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Non-lethal Biochemical Weapons Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Non-lethal Biochemical Weapons Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Non-lethal Biochemical Weapons Market Share by Country (2021-2026) Table 149. Asia-Pacific Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Non-lethal Biochemical Weapons Market Share Forecast by Country (2027-2032) Table 151. Latin America Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 153. Latin America Non-lethal Biochemical Weapons Sales Market Share by Country (2021-2026) Table 154. Latin America Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Non-lethal Biochemical Weapons Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Non-lethal Biochemical Weapons Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Non-lethal Biochemical Weapons Market Share by Country (2021-2026) Table 159. Latin America Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Non-lethal Biochemical Weapons Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Non-lethal Biochemical Weapons Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Non-lethal Biochemical Weapons Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Non-lethal Biochemical Weapons Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Non-lethal Biochemical Weapons Market Share by Country (2021-2026) Table 169. Middle East and Africa Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Non-lethal Biochemical Weapons Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Non-lethal Biochemical Weapons Distributors List Table 174. Non-lethal Biochemical Weapons Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Non-lethal Biochemical Weapons Image Figure 2. Global Non-lethal Biochemical Weapons Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-lethal Biochemical Weapons Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-lethal Biochemical Weapons Sales (2021-2032) & (k units) Figure 5. Directed Energy Image Figure 6. Global Directed Energy Sales YoY Growth (2021-2032) & (k units) Figure 7. Direct Contact Image Figure 8. Global Direct Contact Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Non-lethal Biochemical Weapons Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Non-lethal Biochemical Weapons Market Share by Type 2025 VS 2032 Figure 11. North America Non-lethal Biochemical Weapons Sales Market Share in Volume by Type in 2025 Figure 12. North America Non-lethal Biochemical Weapons Sales Market Share in Value by Type in 2025 Figure 13. Europe Non-lethal Biochemical Weapons Sales Market Share in Volume by Type in 2025 Figure 14. Europe Non-lethal Biochemical Weapons Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Non-lethal Biochemical Weapons Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Non-lethal Biochemical Weapons Sales Market Share in Value by Type in 2025 Figure 17. Latin America Non-lethal Biochemical Weapons Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Non-lethal Biochemical Weapons Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Non-lethal Biochemical Weapons Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Non-lethal Biochemical Weapons Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Non-lethal Biochemical Weapons Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Military Forces Image Figure 24. Global Military Forces Sales YoY Growth (2021-2032) & (k units) Figure 25. Law Enforcement Agencies Image Figure 26. Global Law Enforcement Agencies Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Non-lethal Biochemical Weapons Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Non-lethal Biochemical Weapons Market Share by Application 2025 VS 2032 Figure 29. North America Non-lethal Biochemical Weapons Sales Market Share in Volume by Application in 2025 Figure 30. North America Non-lethal Biochemical Weapons Sales Market Share in Value by Application in 2025 Figure 31. Europe Non-lethal Biochemical Weapons Sales Market Share in Volume by Application in 2025 Figure 32. Europe Non-lethal Biochemical Weapons Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Non-lethal Biochemical Weapons Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Non-lethal Biochemical Weapons Sales Market Share in Value by Application in 2025 Figure 35. Latin America Non-lethal Biochemical Weapons Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Non-lethal Biochemical Weapons Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Non-lethal Biochemical Weapons Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Non-lethal Biochemical Weapons Sales Market Share in Value by Application in 2025 Figure 39. North America Non-lethal Biochemical Weapons Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Non-lethal Biochemical Weapons Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Non-lethal Biochemical Weapons Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Non-lethal Biochemical Weapons Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Non-lethal Biochemical Weapons Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Non-lethal Biochemical Weapons Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Non-lethal Biochemical Weapons Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Non-lethal Biochemical Weapons Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Non-lethal Biochemical Weapons Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Non-lethal Biochemical Weapons Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Non-lethal Biochemical Weapons Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Non-lethal Biochemical Weapons Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Non-lethal Biochemical Weapons Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Non-lethal Biochemical Weapons Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Non-lethal Biochemical Weapons Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Non-lethal Biochemical Weapons Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Non-lethal Biochemical Weapons Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Non-lethal Biochemical Weapons Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Non-lethal Biochemical Weapons Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Non-lethal Biochemical Weapons Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Non-lethal Biochemical Weapons Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Non-lethal Biochemical Weapons Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Directed Energy
  • Direct Contact
Applications
  • Military Forces
  • Law Enforcement Agencies
Companies covered
  • Lamperd Less Lethal
  • BAE Systems, Inc.
  • QinetiqGroup, Inc.
  • General Dynamics Corporation
  • TASER International,Inc.
  • Moog, Inc.
  • Raytheon Company
  • Chemring Group PLC.
  • Textron Systems, Corp
  • LRAD Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-lethal Biochemical Weapons Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-lethal Biochemical Weapons Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-lethal Biochemical Weapons Market by Type
  6. 1.3.1 Directed Energy
  7. 1.3.2 Direct Contact
  8. 1.4 Global Non-lethal Biochemical Weapons Market Size by Type
  9. 1.4.1 Global Non-lethal Biochemical Weapons Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Non-lethal Biochemical Weapons Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Non-lethal Biochemical Weapons Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-lethal Biochemical Weapons Industry Trends
  2. 2.2 Non-lethal Biochemical Weapons Industry Drivers
  3. 2.3 Non-lethal Biochemical Weapons Industry Opportunities and Challenges
  4. 2.4 Non-lethal Biochemical Weapons Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-lethal Biochemical Weapons Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-lethal Biochemical Weapons Sales (2021-2026)
  3. 3.3 Global Top Players by Non-lethal Biochemical Weapons Price (2021-2026)
  4. 3.4 Global Non-lethal Biochemical Weapons Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-lethal Biochemical Weapons Major Company Production Sites & Headquarters
  6. 3.6 Global Non-lethal Biochemical Weapons Company, Product Type & Application
  7. 3.7 Global Non-lethal Biochemical Weapons Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-lethal Biochemical Weapons Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-lethal Biochemical Weapons Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-lethal Biochemical Weapons Tier 1, Tier 2, and Tier 3
4 Non-lethal Biochemical Weapons Regional Status and Outlook
  1. 4.1 Global Non-lethal Biochemical Weapons Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-lethal Biochemical Weapons Historic Market Size by Region
  3. 4.2.1 Global Non-lethal Biochemical Weapons Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-lethal Biochemical Weapons Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-lethal Biochemical Weapons Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-lethal Biochemical Weapons Forecasted Market Size by Region
  7. 4.3.1 Global Non-lethal Biochemical Weapons Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-lethal Biochemical Weapons Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-lethal Biochemical Weapons Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-lethal Biochemical Weapons by Application
  1. 5.1 Non-lethal Biochemical Weapons Market by Application
  2. 5.1.1 Military Forces
  3. 5.1.2 Law Enforcement Agencies
  4. 5.2 Global Non-lethal Biochemical Weapons Market Size by Application
  5. 5.2.1 Global Non-lethal Biochemical Weapons Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Non-lethal Biochemical Weapons Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Non-lethal Biochemical Weapons Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Lamperd Less Lethal
  2. 6.1.1 Lamperd Less Lethal Company Information
  3. 6.1.2 Lamperd Less Lethal Business Overview
  4. 6.1.3 Lamperd Less Lethal Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Lamperd Less Lethal Non-lethal Biochemical Weapons Product Portfolio
  6. 6.1.5 Lamperd Less Lethal Recent Developments
  7. 6.2 BAE Systems, Inc.
  8. 6.2.1 BAE Systems, Inc. Company Information
  9. 6.2.2 BAE Systems, Inc. Business Overview
  10. 6.2.3 BAE Systems, Inc. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BAE Systems, Inc. Non-lethal Biochemical Weapons Product Portfolio
  12. 6.2.5 BAE Systems, Inc. Recent Developments
  13. 6.3 QinetiqGroup, Inc.
  14. 6.3.1 QinetiqGroup, Inc. Company Information
  15. 6.3.2 QinetiqGroup, Inc. Business Overview
  16. 6.3.3 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Product Portfolio
  18. 6.3.5 QinetiqGroup, Inc. Recent Developments
  19. 6.4 General Dynamics Corporation
  20. 6.4.1 General Dynamics Corporation Company Information
  21. 6.4.2 General Dynamics Corporation Business Overview
  22. 6.4.3 General Dynamics Corporation Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 General Dynamics Corporation Non-lethal Biochemical Weapons Product Portfolio
  24. 6.4.5 General Dynamics Corporation Recent Developments
  25. 6.5 TASER International,Inc.
  26. 6.5.1 TASER International,Inc. Company Information
  27. 6.5.2 TASER International,Inc. Business Overview
  28. 6.5.3 TASER International,Inc. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 TASER International,Inc. Non-lethal Biochemical Weapons Product Portfolio
  30. 6.5.5 TASER International,Inc. Recent Developments
  31. 6.6 Moog, Inc.
  32. 6.6.1 Moog, Inc. Company Information
  33. 6.6.2 Moog, Inc. Business Overview
  34. 6.6.3 Moog, Inc. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Moog, Inc. Non-lethal Biochemical Weapons Product Portfolio
  36. 6.6.5 Moog, Inc. Recent Developments
  37. 6.7 Raytheon Company
  38. 6.7.1 Raytheon Company Company Information
  39. 6.7.2 Raytheon Company Business Overview
  40. 6.7.3 Raytheon Company Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Raytheon Company Non-lethal Biochemical Weapons Product Portfolio
  42. 6.7.5 Raytheon Company Recent Developments
  43. 6.8 Chemring Group PLC.
  44. 6.8.1 Chemring Group PLC. Company Information
  45. 6.8.2 Chemring Group PLC. Business Overview
  46. 6.8.3 Chemring Group PLC. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chemring Group PLC. Non-lethal Biochemical Weapons Product Portfolio
  48. 6.8.5 Chemring Group PLC. Recent Developments
  49. 6.9 Textron Systems, Corp
  50. 6.9.1 Textron Systems, Corp Company Information
  51. 6.9.2 Textron Systems, Corp Business Overview
  52. 6.9.3 Textron Systems, Corp Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Textron Systems, Corp Non-lethal Biochemical Weapons Product Portfolio
  54. 6.9.5 Textron Systems, Corp Recent Developments
  55. 6.10 LRAD Corporation
  56. 6.10.1 LRAD Corporation Company Information
  57. 6.10.2 LRAD Corporation Business Overview
  58. 6.10.3 LRAD Corporation Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 LRAD Corporation Non-lethal Biochemical Weapons Product Portfolio
  60. 6.10.5 LRAD Corporation Recent Developments
7 North America by Country
  1. 7.1 North America Non-lethal Biochemical Weapons Sales by Country
  2. 7.1.1 North America Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-lethal Biochemical Weapons Sales by Country (2021-2026)
  4. 7.1.3 North America Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-lethal Biochemical Weapons Market Size by Country
  6. 7.2.1 North America Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-lethal Biochemical Weapons Sales by Country
  2. 8.1.1 Europe Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-lethal Biochemical Weapons Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-lethal Biochemical Weapons Market Size by Country
  6. 8.2.1 Europe Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-lethal Biochemical Weapons Sales by Country
  2. 9.1.1 Asia-Pacific Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-lethal Biochemical Weapons Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-lethal Biochemical Weapons Market Size by Country
  6. 9.2.1 Asia-Pacific Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-lethal Biochemical Weapons Sales by Country
  2. 10.1.1 South America Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-lethal Biochemical Weapons Sales by Country (2021-2026)
  4. 10.1.3 South America Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-lethal Biochemical Weapons Market Size by Country
  6. 10.2.1 South America Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-lethal Biochemical Weapons Sales by Country
  2. 11.1.1 Middle East and Africa Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-lethal Biochemical Weapons Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-lethal Biochemical Weapons Market Size by Country
  6. 11.2.1 Middle East and Africa Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-lethal Biochemical Weapons Value Chain Analysis
  2. 12.1.1 Non-lethal Biochemical Weapons Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-lethal Biochemical Weapons Production Mode & Process
  7. 12.2 Non-lethal Biochemical Weapons Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-lethal Biochemical Weapons Distributors
  10. 12.2.3 Non-lethal Biochemical Weapons Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research